[Apoptosis-inducing effect of alternol on mouse lymphocyte leukemia cells and its mechanism]

Zhao-zhe Liu1, Jie-peng Chen, Su-lan Zhao

  • 1School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100083, China.

Insights

Alternol, derived from Alternaria alternata, effectively inhibits mouse leukemia L1210 cell proliferation. It induces apoptosis via a mitochondria-dependent pathway, involving reactive oxygen species and caspase activation.

Area of Science:

  • Pharmacology
  • Cancer Biology
  • Cell Biology

Background:

  • Leukemia L1210 cells are a common model for studying anti-cancer agents.
  • Alternol is a compound isolated from Alternaria alternata var. monosporus.
  • Understanding the mechanisms of novel compounds in inducing cancer cell apoptosis is crucial.

Purpose of the Study:

  • To investigate the apoptosis-inducing effects of Alternol on mouse lymphocyte leukemia (L1210) cells.
  • To elucidate the underlying mechanisms of Alternol-induced apoptosis in L1210 cells.

Main Methods:

  • Cell viability was assessed using the MTT assay.
  • Apoptosis was detected through morphological assessment (AO/EB staining), DNA electrophoresis, and flow cytometry.
  • Western blotting was employed to analyze apoptosis-related protein expression, alongside reactive oxygen species (ROS) and mitochondrial membrane potential (Δψm) measurements.

Main Results:

  • Alternol demonstrated dose-dependent inhibition of L1210 cell proliferation.
  • Apoptotic morphological features, elevated apoptosis rates, and DNA laddering were observed.
  • Alternol induced ROS production, decreased mitochondrial membrane potential, down-regulated Bcl-2, and up-regulated Caspase-3 and Caspase-9.

Conclusions:

  • Alternol effectively inhibits L1210 cell proliferation and induces apoptosis.
  • The apoptosis is mediated through a mitochondria-dependent pathway.
  • Alternol shows potential as an anti-leukemic agent.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...